Logo image of ALSEN.PA

SENSORION SA (ALSEN.PA) Stock Price, Quote, News and Overview

EPA:ALSEN - Euronext Paris - Matif - FR0012596468 - Common Stock - Currency: EUR

0.57  -0.01 (-2.4%)

ALSEN.PA Quote, Performance and Key Statistics

SENSORION SA

EPA:ALSEN (3/7/2025, 7:00:00 PM)

0.57

-0.01 (-2.4%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High0.98
52 Week Low0.54
Market Cap171.28M
Shares300.50M
Float211.83M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)03-12 2025-03-12/amc
IPO04-21 2015-04-21


ALSEN.PA short term performance overview.The bars show the price performance of ALSEN.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15 -20 -25

ALSEN.PA long term performance overview.The bars show the price performance of ALSEN.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 40 60

The current stock price of ALSEN.PA is 0.57 EUR. In the past month the price decreased by -10.38%. In the past year, price decreased by -34.86%.

SENSORION SA / ALSEN Daily stock chart

ALSEN.PA Competitors/Peers

The largest stocks on the EU markets in the "Biotechnology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
4AB.DE ABBVIE INC 21.07 346.68B
1ABBV.MI ABBVIE INC 20.82 342.48B
AMG.DE AMGEN INC 16.43 161.21B
1AMGN.MI AMGEN INC 15.84 160.89B
1GILD.MI GILEAD SCIENCES INC 25.67 135.84B
GIS.DE GILEAD SCIENCES INC 25.39 134.40B
VX1.DE VERTEX PHARMACEUTICALS INC 1667.04 115.58B
ARGX.BR ARGENX SE 253.61 33.75B
22UA.DE BIONTECH SE-ADR N/A 24.36B
IDP.DE BIOGEN INC 9.25 20.54B
1BIIB.MI BIOGEN INC 8.39 19.21B
0QF.DE MODERNA INC N/A 13.19B

About ALSEN.PA

Company Profile

ALSEN logo image Sensorion SA is a biopharmaceutical company, which engages in the development of therapies to treat and prevent diseases of the inner ear such as deafness, vertigo, and tinnitus. The company is headquartered in Montpellier, Occitanie and currently employs 61 full-time employees. The company went IPO on 2015-04-21. The firm is principally active in the development of targeted therapeutic solutions to treat inner ear diseases. The firm develops also drug treatments, from molecular biology all the way to animal pharmacology, toxicology, and clinical research and therapeutic solutions to treat vestibular deficits. Sensorion SA is a spin-off of the research team Pathophysiology and Therapy of Vestibular Deficits in Montpellier Neuroscience Institute.

Company Info

SENSORION SA

375, rue du Professeur Joseph Blayac

Montpellier OCCITANIE FR

Employees: 61

Company Website: https://www.sensorion-pharma.com/

Investor Relations: http://sensorion.com/en/investors/

Phone: 33467207730

SENSORION SA / ALSEN.PA FAQ

What is the stock price of SENSORION SA today?

The current stock price of ALSEN.PA is 0.57 EUR. The price decreased by -2.4% in the last trading session.


What is the ticker symbol for SENSORION SA stock?

The exchange symbol of SENSORION SA is ALSEN and it is listed on the Euronext Paris - Matif exchange.


On which exchange is ALSEN.PA stock listed?

ALSEN.PA stock is listed on the Euronext Paris - Matif exchange.


What is the price forecast or stock price prediction for SENSORION SA stock?

12 analysts have analysed ALSEN.PA and the average price target is 2.42 EUR. This implies a price increase of 325% is expected in the next year compared to the current price of 0.57. Check the SENSORION SA stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is SENSORION SA worth?

SENSORION SA (ALSEN.PA) has a market capitalization of 171.28M EUR. This makes ALSEN.PA a Micro Cap stock.


How many employees does SENSORION SA have?

SENSORION SA (ALSEN.PA) currently has 61 employees.


What are the support and resistance levels for SENSORION SA (ALSEN.PA) stock?

SENSORION SA (ALSEN.PA) has a resistance level at 0.59. Check the full technical report for a detailed analysis of ALSEN.PA support and resistance levels.


Is SENSORION SA (ALSEN.PA) expected to grow?

The Revenue of SENSORION SA (ALSEN.PA) is expected to grow by 299.94% in the next year. Check the estimates tab for more information on the ALSEN.PA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy SENSORION SA (ALSEN.PA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does SENSORION SA (ALSEN.PA) stock pay dividends?

ALSEN.PA does not pay a dividend.


When does SENSORION SA (ALSEN.PA) report earnings?

SENSORION SA (ALSEN.PA) will report earnings on 2025-03-12, after the market close.


What is the Price/Earnings (PE) ratio of SENSORION SA (ALSEN.PA)?

SENSORION SA (ALSEN.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.1).


ALSEN.PA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

ALSEN.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to ALSEN.PA. The financial health of ALSEN.PA is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ALSEN.PA Financial Highlights

Over the last trailing twelve months ALSEN.PA reported a non-GAAP Earnings per Share(EPS) of -0.1. The EPS increased by 63.96% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -23.31%
ROE -28.36%
Debt/Equity 0.02
Chartmill High Growth Momentum
EPS Q2Q%65.84%
Sales Q2Q%N/A
EPS 1Y (TTM)63.96%
Revenue 1Y (TTM)N/A

ALSEN.PA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 87% to ALSEN.PA. The Buy consensus is the average rating of analysts ratings from 12 analysts.

For the next year, analysts expect an EPS growth of 58.14% and a revenue growth 299.94% for ALSEN.PA


Ownership
Inst Owners50.29%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts86.67
Price Target2.42 (324.56%)
EPS Next Y58.14%
Revenue Next Year299.94%